NCT02476253View on ClinicalTrials.gov

Sodium Bicarbonate to Treat Severe Acidosis in the Critically Ill

PHASE3CompletedINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

May 5, 2015

Primary Completion Date

May 29, 2017

Study Completion Date

May 29, 2017

Conditions
Metabolic Acidosis
Interventions
DRUG

Sodium Bicarbonate

Intravenous 4.2% Sodium Bicarbonate 125ml to 250ml / 30min up to 1000ml/24h to maintain plasma pH equal or greater than 7.30

Trial Locations (1)

34000

DAR St Eloi, Montpellier

All Listed Sponsors
lead

University Hospital, Montpellier

OTHER

NCT02476253 - Sodium Bicarbonate to Treat Severe Acidosis in the Critically Ill | Biotech Hunter | Biotech Hunter